State TN
Clinical Trials in Tennessee
Recruiting clinical trials with at least one study location in Tennessee. Data updated daily from ClinicalTrials.gov.
Top Conditions in Tennessee
NCT07201948 N/A
Recruiting
Team Lifestyle Immersion Hypertension Control Project
Condition
Hypertension
Enrollment
220 pts
Location
United States
Sponsor
Meharry Medical College
NCT07205900 Phase 2
Recruiting
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Melli...
Condition
Obese
Enrollment
250 pts
Location
United States
Sponsor
Hanmi Pharmaceutical Company L
NCT06806033 Phase 2
Recruiting
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile fo...
Condition
B-Cell Non-Hodgkins Lymphoma
Enrollment
100 pts
Location
United States, Australia, Canada
Sponsor
Hoffmann-La Roche
NCT03999983 N/A
Recruiting
Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)
Condition
Vertebral Artery Stenosis
Enrollment
150 pts
Location
United States
Sponsor
St. Louis University
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT04928846 Phase 3
Recruiting
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Teliso...
Condition
Non Small Cell Lung Cancer
Enrollment
698 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
NCT00674388 N/A
Recruiting
The Pediatric Anesthesia Quality Improvement Project
Condition
Surgery
Enrollment
5,000,000 pts
Location
United States
Sponsor
The Society for Pediatric Anes
NCT05431270 Phase 1, Phase 2
Recruiting
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Admin...
Condition
Non Small Cell Lung Cancer
Enrollment
40 pts
Location
United States
Sponsor
Phanes Therapeutics
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT02468024 Phase 3
Recruiting
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR)...
Condition
Non-Small Cell Lung Cancer
Enrollment
272 pts
Location
United States, Australia, Canada
Sponsor
University of Texas Southweste
NCT06132503 Phase 1
Recruiting
Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With...
Condition
Relapsed or Refractory Lymphomas
Enrollment
110 pts
Location
United States
Sponsor
Lantern Pharma Inc.
NCT05354141 Phase 3
Recruiting
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (...
Condition
Acute Respiratory Distress Syndrome
Enrollment
970 pts
Location
United States
Sponsor
Direct Biologics, LLC
NCT06113003 EARLY_Phase 1
Recruiting
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic ...
Condition
HIV
Enrollment
63 pts
Location
United States
Sponsor
Vanderbilt University Medical
NCT05975333 N/A
Recruiting
Writing Intervention With Adolescents and Young Adults With Cancer
Condition
Cancer Patients
Enrollment
26 pts
Location
United States
Sponsor
St. Jude Children's Research H
NCT06602232 Phase 1
Recruiting
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
Condition
Alopecia Areata
Enrollment
80 pts
Location
United States, Australia, New Zealand
Sponsor
Dren Bio
NCT06541704 Phase 3
Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With ...
Condition
Age-related Macular Degeneration (AMD)
Enrollment
975 pts
Location
United States, Austria, Canada
Sponsor
Regeneron Pharmaceuticals
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/...
Condition
Breast Cancer
Enrollment
1,000 pts
Location
United States, Australia, Canada
Sponsor
Olema Pharmaceuticals, Inc.
NCT06675344 N/A
Recruiting
The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud P...
Condition
Systemic Sclerosis (SSc)
Enrollment
160 pts
Location
United States
Sponsor
Robyn T. Domsic, MD, MPH
NCT07044336 Phase 3
Recruiting
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected End...
Condition
Endometrial Cancer
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06690398 Phase 3
Recruiting
Multicenter Study of Lumateperone for the Treatment of Irritability Associated W...
Condition
Irritability Associated With Autism Spectrum Disorder
Enrollment
174 pts
Location
United States
Sponsor
Intra-Cellular Therapies, Inc.
NCT07006675 Phase 3
Recruiting
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Frac...
Condition
Tibial Fractures
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
Major Extremity Trauma Researc
NCT06625775 Phase 1
Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Condition
Solid Tumor, Adult
Enrollment
392 pts
Location
United States, Australia, France
Sponsor
TheRas, Inc., d/b/a BBOT (Brid
NCT05954312 Phase 1
Recruiting
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-1300...
Condition
Advanced Solid Tumors
Enrollment
290 pts
Location
United States, South Korea, Spain
Sponsor
Vividion Therapeutics, Inc.
NCT07055451 Phase 1
Recruiting
Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to ...
Condition
HIV-1-infection
Enrollment
16 pts
Location
United States, South Africa
Sponsor
Gilead Sciences
NCT06685757 Phase 3
Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in A...
Condition
Antibody-mediated Rejection
Enrollment
120 pts
Location
United States, Argentina, Australia
Sponsor
Biogen